In an effort to address the treatment needs of its hemophilia population, the Armenian government will purchase approximately $60,000 worth of factor VIII (FVIII) product. The Armenian Health Care Ministry will attempt to build on this purchase by including a permanent FVIII allocation in future budgets to provide treatment for the approximately 260 Armenians with hemophilia. The World Federation of Hemophilia has been working with Armenia and other governments worldwide to help augment hemophilia treatment resources.

 

In addition, David Khanzratyan, vice president of the Armenian Association of Hemophilia Patients, has stated that a hemophilia treatment center and laboratory will open at the Blood Transfusion Institute in the capital city of Yerevan. It is estimated that approximately 75% of the world hemophilia population goes without adequate treatment.

 

Source: ARMINFO News Agency (Armenia), November 16, 2005